Skip to main content
Psych Capital Plc logo

Psych Capital Plc — Investor Relations & Filings

Ticker · PSY ISIN · GB00BL6CJQ54 LEI · 213800WXCQ1C6GPLHH68 IL Professional, scientific and technical activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2023-06-22 Regulatory Filings
Country GB United Kingdom
Listing IL PSY

About Psych Capital Plc

https://psych.capital/

Shortwave Life Sciences Plc, formerly Psych Capital Plc, is a biopharmaceutical company that originates and develops innovative treatments for mental healthcare. The company's primary clinical program focuses on developing a psilocybin-based therapy for anorexia nervosa, a condition with no currently approved medication. It employs an IP-driven approach, leveraging global partnerships and an experienced leadership team to optimize its drug discovery and development processes. Through its subsidiary, Blossom Analysis, the company also provides a data and insights platform for the psychedelic healthcare industry.

Recent filings

Filing Released Lang Actions
PSYCH Symposium 2023: 6th July 2023
Regulatory Filings Classification · 99% confidence The document is a formal announcement disseminated via RNS (RNS Number: 4899D), which is the news service of the London Stock Exchange. The content announces an upcoming event, the 'PSYCH Symposium 2023', detailing the date, location, speakers, and purpose. This is not a core financial report (like 10-K, IR, or ER), nor is it a specific transaction report (like DIRS or POS). It is an announcement of general corporate activity related to an industry event the company is involved in or hosting. Since it is a general regulatory announcement distributed through the official news service (RNS) and does not fit into the more specific categories like AGM-R (it's an announcement about an event, not the meeting materials themselves), it best fits the general Regulatory Filings category (RNS) or potentially AGM-R if the symposium was the AGM, but the text refers to it as 'PSYCH Symposium 2023' and not the Annual General Meeting. Given the structure and the explicit mention of RNS distribution, RNS is the most appropriate fallback for a general corporate update/announcement.
2023-06-22 English
Acquisition of Short Wave Pharma for £3.5m
Regulatory Filings Classification · 99% confidence The document is a formal announcement dated June 19, 2023, originating from 'Psych Capital PLC' and distributed via the 'RNS Number : 1182D' mechanism, which strongly suggests a regulatory filing or market communication. The content details a significant corporate action: the 'Acquisition of Short Wave Pharma for £3.5m via Cash and Equity' and concurrent 'Board Appointments'. This type of material event disclosure, covering M&A, share issuance (new Ordinary Shares), and director changes, is typically disseminated through official regulatory channels. Since it is a comprehensive announcement of a major transaction and management change, it is not merely a Report Publication Announcement (RPA). It is a significant corporate event disclosure. While it involves capital changes (SHA) and M&A (TAR), the primary nature of the RNS release is a broad corporate update. Given the context of RNS distribution and the nature of the announcement (major acquisition and board changes), it fits best under the general 'Regulatory Filings' (RNS) category, which serves as a broad category for official market disclosures that aren't strictly one of the other specific reports (like 10-K or ER). However, because it explicitly details the acquisition terms and share issuance, it strongly relates to Capital/Financing (CAP) and M&A (TAR). Since RNS is the distribution channel and the content is a major corporate event announcement, RNS is a strong candidate, but TAR (M&A Activity) or CAP (Capital/Financing Update) are more specific to the core event. Given the focus on the acquisition terms and the resulting share issuance, TAR (M&A Activity) is the most precise fit for the primary subject matter, although RNS is the delivery mechanism.
2023-06-19 English
PSYCH SYMPOSIUM 6th JULY, LONDON
Regulatory Filings Classification · 100% confidence The document is a short announcement released via RNS (RNS Number : 2576X) on April 25, 2023. It announces an upcoming event, the 'PSYCH Symposium' scheduled for July 6th, 2023, and provides details about the event, its purpose, and registration information. It is not a formal financial report (like 10-K, IR, ER) nor is it a specific regulatory filing like a Director's Dealing or a Dividend Notice. Since it is a general announcement disseminated through the RNS system, and it doesn't fit any of the other highly specific categories (like AGM-R, CT, CAP, etc.), it falls best under the general regulatory announcement category, RNS, which serves as a fallback for miscellaneous regulatory news releases.
2023-04-25 English
Interim Results to 31 October 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Interim Results for the Six Months Ended 31 October 2022' and contains comprehensive financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows. It provides a detailed management review of the period's performance. As it contains substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2023
2023-01-31 English
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states it is an announcement regarding the 'Result of Annual General Meeting' held on November 28, 2022, confirming that 'all resolutions were duly passed.' This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM. Although it is a result announcement, the content is focused on the AGM outcome, making AGM-R the most specific fit over a general Regulatory Filing (RNS) or a Voting Results Declaration (DVA), as DVA is usually for the detailed vote counts, whereas this is a high-level confirmation following the meeting.
2022-11-28 English
Notice of Annual General Meeting
AGM Information Classification · 98% confidence The document explicitly states 'Notice of Annual General Meeting' and provides the date, time, and location for the '2022 Annual General Meeting ("AGM")'. It also mentions that the 'Notice of the AGM was posted to shareholders'. This content directly relates to the scheduling and announcement of the AGM. Although it is an announcement, the specific category for AGM-related materials, including the notice, is AGM-R (AGM Information), which covers presentations and materials shared during the AGM. Since this is the formal notice of the meeting itself, AGM-R is the most precise fit over a general RPA or RNS.
2022-11-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.